4th Bacteriophage Therapy Summit
Evvnt Promotion / evvnt
14.02.2022 - 16.02.2022 Online
Time: 09:00 to 17:00
Temas de la conferencia
With increasing regulatory flexibility for phage-based applications, address critical questions to help your phage technologies advance through commercial development. Are you ready to gain the insights needed to radically transform your bacteriophage therapies into commercially viable products?
With increasing regulatory flexibility for phage-based applications, address critical questions to help your phage technologies advance through commercial development. Are you ready to gain the insights needed to radically transform your bacteriophage therapies into commercially viable products?
Organizador profesional (PCO)
Hanson Wade
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/923318-3?pid=4832
Speakers: Bob Blasdel, Research Director, Vesale Pharma , Cara Fiore, Microbiologist, FDA Office of Vaccines Research and Review , and more.
Brochure: https://go.evvnt.com/923318-3?pid=4832
Speakers: Bob Blasdel, Research Director, Vesale Pharma , Cara Fiore, Microbiologist, FDA Office of Vaccines Research and Review , and more.
Información e inscripción:
https://go.evvnt.com/923318-2?pid=4832
Mr. Customer Service
Medicina General
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
